Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Recruiting · NCT05422911 · Registry updated 2026-06-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. | Genital Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic malignant neoplasm, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2026-06-15 | NCT05422911 |
12 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Corporal Michael J. Crescenz VA Medical Center | Philadelphia | United States | 5 |
| James A. Haley Veterans Administration Hospital | Tampa | United States | 1 |
| James J. Peters VA Medical Center | The Bronx | United States | 16 |
| Michael E. DeBakey VA Medical Center | Houston | United States | 18 |
| VA Ann Arbor Healthcare System | Ann Arbor | United States | 4 |
| VA Greater Los Angeles Healthcare System | Los Angeles | United States | 15 |
| VA Hudson Valley Health Care System | Wappingers Falls | United States | 1 |
| VA New York Harbor Healthcare System | New York | United States | 9 |
| VA Portland Health Care System | Portland | United States | 12 |
| VA Puget Sound Health Care System | Seattle | United States | 16 |
| VA St. Louis Health Care System | St Louis | United States | 3 |
| W.G. Bill Hefner Medical Center | Salisbury | United States | 1 |